Pharmaceuticals & Medical Devices
Today’s pharmaceutical and medical device organizations operate amidst a highly competitive marketplace and increasing regulatory and government scrutiny. Drawing on unmatched experience, specialized knowledge and a collaborative, action-oriented approach, Huron has delivered customized financial and operational solutions that have provided significant value for more than 60 leading life sciences companies. 
Pharmaceuticals & Medical Devices INSIGHTS
Perspective: Drugs and Devices Do Mix: Challenges and Opportunities for the Integrated Life Sciences Manufacturer - Presentation from Model N Rainmaker 2013
This presentation provides an overview of the strategic and organizational challenges companies in acquisition or consolidation face and considerations for avoiding both “one-size-fits-all” or highly customized approaches. » MORE

Interview: The Promise of Big Data for Gaining Insight in the Pharmaceutical Industry
Advances in Big Data promise to help pharmaceutical companies identify and segment customers, and assure compliance with federal regulations.» MORE

Whitepaper: Drugs and Devices Do Mix: Challenges and Opportunities for the Integrated Life Sciences Manufacturer
This White Paper spells out an approach to taming the challenges of merging the operations, technical specifications, regulatory regimes, and cultures of pharmaceutical and medical device companies.» MORE


Related Expertise
PROFESSIONALS
Manny Tzavlakis
Manny Tzavlakis
Managing Director

Template:
Mark DeWyngaert
Mark A. DeWyngaert
Managing Director

Template:
Mark Linver
Mark Linver
Managing Director

Template:
Paul Silver
Paul J. Silver
Managing Director

Template:
Resource

International Medical Device Compliance Code Compendium

First published as a bound reference guide in 2007, the International Medical Device Compliance Code Compendium provides a comprehensive listing of region- and country-level codes of conduct developed by self-regulatory bodies in the medical device sector as well as comparative analyses with the most recent guidance provided by AdvaMed.